Clinical trial

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

NCT07040592

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-15

PhasePHASE2

Study timeline

Study start (actual)2026-01-15Date precision: day

Registry last updated2026-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alcohol Use Disorder (AUD)unresolved

HIVunresolved

Interventions

semaglutideDRUG · verified · RxNorm: semaglutide

Sponsors & collaborators

Yale Universitylead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator

Mapped research locations

DecaturGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07040592 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.